• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

下呼吸道微生态失调加重轻中度慢性阻塞性肺疾病肺部炎症损伤。

Lower Airway Dysbiosis Augments Lung Inflammatory Injury in Mild-to-Moderate Chronic Obstructive Pulmonary Disease.

机构信息

Division of Pulmonary and Critical Care Medicine.

Department of Medicine.

出版信息

Am J Respir Crit Care Med. 2023 Nov 15;208(10):1101-1114. doi: 10.1164/rccm.202210-1865OC.

DOI:10.1164/rccm.202210-1865OC
PMID:37677136
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10867925/
Abstract

Chronic obstructive pulmonary disease (COPD) is associated with high morbidity, mortality, and healthcare costs. Cigarette smoke is a causative factor; however, not all heavy smokers develop COPD. Microbial colonization and infections are contributing factors to disease progression in advanced stages. We investigated whether lower airway dysbiosis occurs in mild-to-moderate COPD and analyzed possible mechanistic contributions to COPD pathogenesis. We recruited 57 patients with a >10 pack-year smoking history: 26 had physiological evidence of COPD, and 31 had normal lung function (smoker control subjects). Bronchoscopy sampled the upper airways, lower airways, and environmental background. Samples were analyzed by 16S rRNA gene sequencing, whole genome, RNA metatranscriptome, and host RNA transcriptome. A preclinical mouse model was used to evaluate the contributions of cigarette smoke and dysbiosis on lower airway inflammatory injury. Compared with smoker control subjects, microbiome analyses showed that the lower airways of subjects with COPD were enriched with common oral commensals. The lower airway host transcriptomics demonstrated differences in markers of inflammation and tumorigenesis, such as upregulation of IL-17, IL-6, ERK/MAPK, PI3K, MUC1, and MUC4 in mild-to-moderate COPD. Finally, in a preclinical murine model exposed to cigarette smoke, lower airway dysbiosis with common oral commensals augments the inflammatory injury, revealing transcriptomic signatures similar to those observed in human subjects with COPD. Lower airway dysbiosis in the setting of smoke exposure contributes to inflammatory injury early in COPD. Targeting the lower airway microbiome in combination with smoking cessation may be of potential therapeutic relevance.

摘要

慢性阻塞性肺疾病(COPD)与高发病率、高死亡率和高医疗成本相关。香烟烟雾是一个致病因素;然而,并非所有重度吸烟者都会发展为 COPD。微生物定植和感染是疾病进展到晚期的一个促成因素。我们研究了轻度至中度 COPD 是否会发生下呼吸道失调,并分析了对 COPD 发病机制的可能机制贡献。我们招募了 57 名有>10 包年吸烟史的患者:26 名有生理上的 COPD 证据,31 名有正常的肺功能(吸烟者对照)。支气管镜检查采集上呼吸道、下呼吸道和环境背景样本。通过 16S rRNA 基因测序、全基因组、RNA 宏转录组和宿主 RNA 转录组分析样本。使用临床前小鼠模型评估香烟烟雾和失调对下呼吸道炎症损伤的贡献。与吸烟者对照相比,微生物组分析表明 COPD 患者的下呼吸道富含常见的口腔共生菌。下呼吸道宿主转录组学显示了炎症和肿瘤发生标志物的差异,例如在轻度至中度 COPD 中,IL-17、IL-6、ERK/MAPK、PI3K、MUC1 和 MUC4 的上调。最后,在暴露于香烟烟雾的临床前小鼠模型中,常见口腔共生菌的下呼吸道失调会加剧炎症损伤,揭示了与 COPD 患者相似的转录组特征。在吸烟暴露的情况下,下呼吸道失调会导致 COPD 早期的炎症损伤。针对下呼吸道微生物组与戒烟相结合可能具有潜在的治疗相关性。

相似文献

1
Lower Airway Dysbiosis Augments Lung Inflammatory Injury in Mild-to-Moderate Chronic Obstructive Pulmonary Disease.下呼吸道微生态失调加重轻中度慢性阻塞性肺疾病肺部炎症损伤。
Am J Respir Crit Care Med. 2023 Nov 15;208(10):1101-1114. doi: 10.1164/rccm.202210-1865OC.
2
Lung microbiome composition and bronchial epithelial gene expression in patients with COPD versus healthy individuals: a bacterial 16S rRNA gene sequencing and host transcriptomic analysis.慢性阻塞性肺疾病患者与健康个体的肺部微生物群组成及支气管上皮基因表达:细菌16S rRNA基因测序和宿主转录组分析
Lancet Microbe. 2021 Jul;2(7):e300-e310. doi: 10.1016/S2666-5247(21)00035-5. Epub 2021 Apr 23.
3
Increased Expression of lncRNA Regulates the Cigarette Smoke and COPD Associated Airway Inflammation and Mucous Cell Hyperplasia.长链非编码 RNA 的表达增加调节香烟烟雾和 COPD 相关的气道炎症和黏液细胞增生。
Front Immunol. 2022 Jun 14;13:803362. doi: 10.3389/fimmu.2022.803362. eCollection 2022.
4
Chronic cigarette smoke exposure and pneumococcal infection induce oropharyngeal microbiota dysbiosis and contribute to long-lasting lung damage in mice.慢性香烟烟雾暴露和肺炎链球菌感染可诱导口咽微生物群落失调,并导致小鼠肺部的长期损伤。
Microb Genom. 2020 Dec;6(12). doi: 10.1099/mgen.0.000485. Epub 2020 Dec 9.
5
Gut microbiota dysbiosis contributes to the development of chronic obstructive pulmonary disease.肠道微生物失调导致慢性阻塞性肺疾病的发生。
Respir Res. 2021 Oct 25;22(1):274. doi: 10.1186/s12931-021-01872-z.
6
Gut Microbiome and Transcriptomic Changes in Cigarette Smoke-Exposed Mice Compared to COPD and CD Patient Datasets.与 COPD 和 CD 患者数据集相比,香烟烟雾暴露小鼠的肠道微生物组和转录组变化。
Int J Mol Sci. 2024 Apr 5;25(7):4058. doi: 10.3390/ijms25074058.
7
Chronic obstructive pulmonary disease upper airway microbiome is associated with select clinical characteristics.慢性阻塞性肺疾病上呼吸道微生物群与某些临床特征有关。
PLoS One. 2019 Jul 23;14(7):e0219962. doi: 10.1371/journal.pone.0219962. eCollection 2019.
8
Cigarette smoke-induced dysbiosis: comparative analysis of lung and intestinal microbiomes in COPD mice and patients.香烟烟雾引起的微生态失调:COPD 小鼠和患者肺部和肠道微生物组的比较分析。
Respir Res. 2024 May 10;25(1):204. doi: 10.1186/s12931-024-02836-9.
9
Airway host-microbiome interactions in chronic obstructive pulmonary disease.慢性阻塞性肺疾病中的气道宿主-微生物组相互作用。
Respir Res. 2019 Jun 6;20(1):113. doi: 10.1186/s12931-019-1085-z.
10
Targeting c-Src Reverses Accelerated GPX-1 mRNA Decay in Chronic Obstructive Pulmonary Disease Airway Epithelial Cells.靶向 c-Src 逆转慢性阻塞性肺疾病气道上皮细胞中加速的 GPX-1 mRNA 衰减。
Am J Respir Cell Mol Biol. 2020 May;62(5):598-607. doi: 10.1165/rcmb.2019-0177OC.

引用本文的文献

1
Pseudomonas aeruginosa-driven airway dysbiosis and machine learning prediction of acute exacerbations in non-cystic fibrosis bronchiectasis: a microbial-inflammatory signature approach.铜绿假单胞菌驱动的气道生态失调与非囊性纤维化支气管扩张症急性加重的机器学习预测:一种微生物-炎症特征方法
BMC Pulm Med. 2025 Sep 1;25(1):419. doi: 10.1186/s12890-025-03892-7.
2
Nrf2 pathway potentially confers protection against cigarette smoke-induced sarcopenia in a mouse model.在小鼠模型中,Nrf2信号通路可能对香烟烟雾诱导的肌肉减少症具有保护作用。
Eur J Med Res. 2025 Aug 25;30(1):798. doi: 10.1186/s40001-025-03079-0.
3
Genetic evidence from Mendelian randomization strengthens the causality between oral microbiome and chronic obstructive pulmonary disease.孟德尔随机化的遗传证据强化了口腔微生物群与慢性阻塞性肺疾病之间的因果关系。
Medicine (Baltimore). 2025 Jul 25;104(30):e43347. doi: 10.1097/MD.0000000000043347.
4
Diagnostic model for COPD patients with nocardia infection: a study based on clinical features and risk factors.慢性阻塞性肺疾病合并诺卡菌感染患者的诊断模型:一项基于临床特征和危险因素的研究
Ther Adv Respir Dis. 2025 Jan-Dec;19:17534666251359139. doi: 10.1177/17534666251359139. Epub 2025 Jul 21.
5
Associations of serum and bronchoalveolar immunoglobulins with lung microbiota diversity, B-cell memory phenotypes, and COPD morbidity and exacerbations.血清和支气管肺泡免疫球蛋白与肺部微生物群多样性、B细胞记忆表型以及慢性阻塞性肺疾病(COPD)发病率和急性加重的关联。
Respir Res. 2025 Jul 18;26(1):250. doi: 10.1186/s12931-025-03310-w.
6
Addressing Knowledge Gaps in the Early Detection of Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation: An Official American Thoracic Society Research Statement.解决造血细胞移植后闭塞性细支气管炎综合征早期检测中的知识空白:美国胸科学会官方研究声明
Am J Respir Crit Care Med. 2025 Aug;211(8):1369-1390. doi: 10.1164/rccm.202506-1352ST.
7
The respiratory microbiome in patients with post-COVID-19 residual lung abnormalities resembles that of healthy individuals and is distinct from idiopathic pulmonary fibrosis.新冠后肺部残留异常患者的呼吸道微生物群与健康个体相似,且与特发性肺纤维化不同。
ERJ Open Res. 2025 May 27;11(3). doi: 10.1183/23120541.00826-2024. eCollection 2025 May.
8
Role of nasal microbiota in regulating host anti-influenza immunity in dogs.鼻腔微生物群在调节犬类宿主抗流感免疫中的作用。
Microbiome. 2025 Jan 27;13(1):27. doi: 10.1186/s40168-025-02031-y.
9
Potential of gut microbiota metabolites in treating COPD: network pharmacology and Mendelian randomization approaches.肠道微生物群代谢产物在治疗慢性阻塞性肺疾病中的潜力:网络药理学和孟德尔随机化方法
Front Microbiol. 2024 Nov 25;15:1416651. doi: 10.3389/fmicb.2024.1416651. eCollection 2024.
10
Exploratory Bronchoalveolar Lavage Fluid Analyses Reveal a High Diversity of Microbiome in NTM Lung Disease and a Low Diversity of Microbiome in Bronchiectasis.探索性支气管肺泡灌洗流体分析揭示了非结核分枝杆菌肺病中微生物群的高度多样性以及支气管扩张症中微生物群的低多样性。
Open Respir Arch. 2024 Jun 22;6(4):100351. doi: 10.1016/j.opresp.2024.100351. eCollection 2024 Oct-Dec.

本文引用的文献

1
Airway dysbiosis accelerates lung function decline in chronic obstructive pulmonary disease.气道微生态失调加速慢性阻塞性肺疾病肺功能下降。
Cell Host Microbe. 2023 Jun 14;31(6):1054-1070.e9. doi: 10.1016/j.chom.2023.04.018. Epub 2023 May 18.
2
Multi-omics analyses of airway host-microbe interactions in chronic obstructive pulmonary disease identify potential therapeutic interventions.多组学分析慢性阻塞性肺疾病气道宿主-微生物相互作用,确定潜在的治疗干预措施。
Nat Microbiol. 2022 Sep;7(9):1361-1375. doi: 10.1038/s41564-022-01196-8. Epub 2022 Aug 22.
3
Lung microbiome composition and bronchial epithelial gene expression in patients with COPD versus healthy individuals: a bacterial 16S rRNA gene sequencing and host transcriptomic analysis.慢性阻塞性肺疾病患者与健康个体的肺部微生物群组成及支气管上皮基因表达:细菌16S rRNA基因测序和宿主转录组分析
Lancet Microbe. 2021 Jul;2(7):e300-e310. doi: 10.1016/S2666-5247(21)00035-5. Epub 2021 Apr 23.
4
Lung Microbiota and Metabolites Collectively Associate with Clinical Outcomes in Milder Stage Chronic Obstructive Pulmonary Disease.肺微生物群和代谢物与更轻阶段慢性阻塞性肺疾病的临床结局有相关性。
Am J Respir Crit Care Med. 2022 Aug 15;206(4):427-439. doi: 10.1164/rccm.202110-2241OC.
5
Exploring the Change of Host and Microorganism in Chronic Obstructive Pulmonary Disease Patients Based on Metagenomic and Metatranscriptomic Sequencing.基于宏基因组学和宏转录组学测序探索慢性阻塞性肺疾病患者宿主与微生物的变化
Front Microbiol. 2022 Mar 16;13:818281. doi: 10.3389/fmicb.2022.818281. eCollection 2022.
6
Distinct blood transcriptomic signature of treatment in latent tuberculosis infected individuals at risk of developing active disease.潜伏性结核感染个体发生活动性疾病风险人群中治疗的血液转录组学特征明显不同。
Tuberculosis (Edinb). 2021 Dec;131:102127. doi: 10.1016/j.tube.2021.102127. Epub 2021 Sep 14.
7
Microbial signatures in the lower airways of mechanically ventilated COVID-19 patients associated with poor clinical outcome.机械通气 COVID-19 患者下呼吸道中的微生物特征与不良临床结局相关。
Nat Microbiol. 2021 Oct;6(10):1245-1258. doi: 10.1038/s41564-021-00961-5. Epub 2021 Aug 31.
8
Lung microbiota associations with clinical features of COPD in the SPIROMICS cohort.肺微生物群与 SPIROMICS 队列中 COPD 临床特征的关联。
NPJ Biofilms Microbiomes. 2021 Feb 5;7(1):14. doi: 10.1038/s41522-021-00185-9.
9
Transcriptome network analyses in human coronavirus infections suggest a rational use of immunomodulatory drugs for COVID-19 therapy.转录组网络分析表明,免疫调节药物可合理用于 COVID-19 治疗。
Genomics. 2021 Mar;113(2):564-575. doi: 10.1016/j.ygeno.2020.12.041. Epub 2021 Jan 20.
10
Functional lower airways genomic profiling of the microbiome to capture active microbial metabolism.对微生物组进行功能性下呼吸道基因组分析以捕获活跃的微生物代谢。
Eur Respir J. 2021 Jul 29;58(1). doi: 10.1183/13993003.03434-2020. Print 2021 Jul.